7Baggers
 polypid to present phase 3 shield ii trial results at acs congress  Investing.com Nigeria Wed, 01 Oct 2025 06:35:20 GMT
 PolyPid at Lytham Partners: Strategic Insights on D-PLEX100 By Investing.com  Investing.com Nigeria Tue, 30 Sep 2025 19:35:58 GMT
 PolyPid to present phase 3 SHIELD II trial results at ACS congress  Investing.com Tue, 30 Sep 2025 13:14:03 GMT
 PolyPid (NASDAQ:PYPD) & Cronos Group (NASDAQ:CRON) Head to Head Survey  Defense World Mon, 29 Sep 2025 06:46:41 GMT
 PolyPid Ltd. (NASDAQ:PYPD) Receives $12.40 Consensus PT from Analysts  Defense World Sun, 28 Sep 2025 05:26:31 GMT
 PolyPid (NASDAQ:PYPD) Rating Increased to Hold at Wall Street Zen  Defense World Sat, 27 Sep 2025 05:20:11 GMT
 craig-hallum maintains polypid(pypd.us) with buy rating  富途牛牛 Fri, 26 Sep 2025 18:25:55 GMT
 polypid (nasdaq:pypd) stock price up 2.9% - time to buy?  MarketBeat Tue, 23 Sep 2025 06:35:05 GMT
 polypid (nasdaq:pypd) stock price up 2.9% – time to buy?  Defense World Tue, 23 Sep 2025 06:30:24 GMT
 polypid ltd. (nasdaq:pypd) short interest update  MarketBeat Mon, 22 Sep 2025 08:26:15 GMT
 short interest in polypid ltd. (nasdaq:pypd) declines by 26.6%  MarketBeat Sun, 21 Sep 2025 09:51:46 GMT
 short interest in polypid ltd. (nasdaq:pypd) drops by 26.6%  MarketBeat Thu, 18 Sep 2025 12:26:24 GMT
 short interest in polypid ltd. (nasdaq:pypd) decreases by 26.6%  MarketBeat Thu, 18 Sep 2025 12:26:24 GMT
 PolyPid to Present at Lytham Partners Fall 2025 Investor  GlobeNewswire Wed, 17 Sep 2025 12:45:05 GMT
 Craig-Hallum Maintains PolyPid(PYPD.US) With Buy Rating  富途牛牛 Wed, 17 Sep 2025 07:00:00 GMT
 PolyPid Successfully Completes Israeli Ministry of Health  GlobeNewswire Tue, 16 Sep 2025 07:00:00 GMT
 polypid completes israeli ministry of health gmp inspection  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 published on: 2025-09-14 19:53:07  newser.com Mon, 15 Sep 2025 00:53:07 GMT
 published on: 2025-09-14 03:54:47  newser.com Sun, 14 Sep 2025 08:54:47 GMT
 published on: 2025-09-14 02:03:28  newser.com Sun, 14 Sep 2025 07:03:28 GMT
 published on: 2025-09-13 17:02:46  newser.com Sat, 13 Sep 2025 22:02:46 GMT
 published on: 2025-09-13 06:11:29  Newser Sat, 13 Sep 2025 11:11:29 GMT
 published on: 2025-09-11 19:16:53  Newser Fri, 12 Sep 2025 00:16:53 GMT

PolyPid Ltd
(NASDAQ:PYPD) 

PYPD stock logo

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product includes D-PLEX100, which is in Phase 3 clinical trial for the prevention of sternal (bone) s...

Founded: 2008
Full Time Employees: 57
CEO: Amir Weisberg  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends